Navigate the FDA’s E2B(R3) Mandate with Confidence – Powered by LifeSphere MultiVigilanceMladen Prenc2025-07-30T22:31:29+00:00July 30, 2025|Read More
Frost & Sullivan Recognizes ArisGlobal’s MedDRA Coding Agent InnovationMladen Prenc2026-04-09T09:19:52+00:00July 23, 2025|Read More
Transforming signal detection: why an AI strategy is only as good as the underlying data strategyMladen Prenc2025-06-25T17:02:27+00:00June 25, 2025|Read More
Collaborating for Impact: How BMS is Leveraging AI—and Key Partners—to Transform Patient Safetyfcampbell@arisglobal.com2025-06-18T10:09:08+00:00June 12, 2025|Read More
AI’s next Regulatory target: product change/impact assessmentfcampbell@arisglobal.com2025-06-03T07:59:29+00:00June 3, 2025|Read More
The Reinvention of Life Science RegOps: is AI changing play?Mladen Prenc2025-05-21T19:28:49+00:00May 21, 2025|Read More
From Planning to Launch: How to Implement a New Safety Database and Maximize ROIMladen Prenc2025-05-09T06:45:16+00:00May 9, 2025|Read More
Unlock PV Innovation with GenAI-Powered Modular SolutionsMladen Prenc2025-04-24T09:36:15+00:00April 24, 2025|Read More
Breakthrough 2025: The Highlights You Don’t Want to Miss!Mladen Prenc2025-08-04T15:10:10+00:00April 9, 2025|Read More
AI is alive among us, whichever route we take: Boehringer Ingelheim’s takeaways from Breakthrough 2025Mladen Prenc2025-04-04T06:46:27+00:00April 4, 2025|Read More
Laying the foundations for a GenAI future: Roche’s journeyMladen Prenc2025-02-21T08:49:56+00:00February 21, 2025|Read More
Sharing data: lessons as Regulatory & Safety/PV teams get closerMladen Prenc2025-02-21T08:50:51+00:00February 14, 2025|Read More
